Kidswell Bio Corporation [4584.T]
TOKYO, Apr 01 (Pulse News Wire) – Kidswell Bio Corporation (4584.T) reported the monthly exercise status for its fourth series of unsecured convertible bonds with attached warrant shares and the 23rd issue of warrant shares for March 2026. For the fourth series of unsecured convertible bonds, no shares were delivered during the month, resulting in a total exercised amount of ¥0.
As of the end of March, the remaining unused balance was ¥125 million. There were no significant events related to the exercise of these bonds in March. Regarding the 23rd issue of warrant shares, no shares were exercised during the month either.
The number of unused warrant shares remained at 13,746 (1,374,600 shares). There were no notable occurrences concerning the exercise of these warrant shares in March. The company adhered to the exercise restrictions outlined by the Tokyo Stock Exchange's Securities Listing Regulations Article 434 and the Japan Securities Dealers Association's Rules Governing Subscription Rights Issues, ensuring compliance throughout the reporting period.
🟢 Confidence: High AI-translated content.